Description
Dermaseptin is a cationic antimicrobial peptide (AMP) that exhibits antibacterial activity against Acinetobacter and Pseudomonas. Dermaseptin increases permeability of cell membranes. Dermaseptin also exhibits anticancer chemotherapeutic and anti-angiogenic activities, inhibiting proliferation, colony formation, and capillary formation in vitro as well as tumor growth in animal models of prostate adenocarcinoma.
References
Jiang Z, Vasil AI, Vasil ML, et al. "Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa. Pharmaceuticals (Basel). 2014 Mar 25;7(4):366-91. PMID: 24670666.
Caillon L, Killian JA, Lequin O, et al. Biophysical investigation of the membrane-disrupting mechanism of the antimicrobial and amyloid-like peptide dermaseptin S9. PLoS One. 2013 Oct 11;8(10):e75528. PMID: 24146759.
van Zoggel H, Carpentier G, Dos Santos C, et al. Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2. PLoS One. 2012;7(9):e44351. PMID: 23028527.